Literature DB >> 8254087

Effect of tumour associated tissue eosinophilia on survival of women with stage IB carcinoma of the uterine cervix.

P B Bethwaite1, L J Holloway, M L Yeong, A Thornton.   

Abstract

AIMS: To examine the survival of a group of women with stage IB invasive carcinoma of the uterine cervix, divided according to the expression of tumour associated tissue eosinophilia (TATE).
METHODS: Histological material from 81 women with stage IB squamous and adenosquamous cervical carcinomas before radiotherapy was assessed for the extent of tissue stromal eosinophilia, quantified using antibodies to human major basic protein.
RESULTS: Twenty eight (38%) of the cases demonstrated TATE of over 30 eosinophils/mm2, with 12 (16%) having greater than 100 eosinophils/mm2. Eleven women in the series developed distant spread or recurrent pelvic disease, this group having a stromal eosinophil density significantly less (13.8/mm2) than the remainder (69.9/mm2) (p = 0.03). The actuarial five year survival rate for women with a tumour eosinophil density over 30/mm2 was 92% compared with 70% with a density under 30 mm2, with a significant difference in the survival curves for these two groups (p = 0.03).
CONCLUSIONS: As a univariate parameter, a tumour associated tissue eosinophilia of at least modest proportions is associated with statistically improved survival in women with stage IB cervical carcinomas.

Entities:  

Mesh:

Year:  1993        PMID: 8254087      PMCID: PMC501685          DOI: 10.1136/jcp.46.11.1016

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  Letter: Eosinophilia in bronchogenic carcinoma.

Authors:  T M Healy
Journal:  N Engl J Med       Date:  1974-10-10       Impact factor: 91.245

2.  Cytotoxic properties of the eosinophil major basic protein.

Authors:  G J Gleich; E Frigas; D A Loegering; D L Wassom; D Steinmuller
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

3.  Morphology and survival rates of cervical cancer in Connecticut and southwest England.

Authors:  J C Bailar; L B Thomas; A D Thomson; H Eisenberg; R M Vick
Journal:  Natl Cancer Inst Monogr       Date:  1966-01

4.  Eosinophil infiltration of human colonic carcinomas as a prognostic indicator.

Authors:  T P Pretlow; E F Keith; A K Cryar; A A Bartolucci; A M Pitts; T G Pretlow; P M Kimball; E A Boohaker
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

5.  Tumour-associated eosinophilia in the bladder.

Authors:  D Lowe; C D Fletcher; R L Gower
Journal:  J Clin Pathol       Date:  1984-05       Impact factor: 3.411

6.  Cervical carcinoma in Malawi: a histopathologic study of 260 cases.

Authors:  D Lowe; J Jorizzo; J Chiphangwi; M S Hutt
Journal:  Cancer       Date:  1981-05-15       Impact factor: 6.860

7.  Carcinomas of the cervix with intense stromal eosinophilia.

Authors:  S G Bostrom; W R Hart
Journal:  Cancer       Date:  1981-06-15       Impact factor: 6.860

8.  Intense eosinophilic stromal infiltration in carcinoma of the uterine cervix: a clinicopathologic study of 14 cases.

Authors:  D S Kapp; V A LiVolsi
Journal:  Gynecol Oncol       Date:  1983-08       Impact factor: 5.482

9.  The prognosis of adenosquamous carcinomas of the uterine cervix.

Authors:  P Bethwaite; M L Yeong; L Holloway; B Robson; G Duncan; D Lamb
Journal:  Br J Obstet Gynaecol       Date:  1992-09

Review 10.  Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review.

Authors:  J C Underwood
Journal:  Br J Cancer       Date:  1974-12       Impact factor: 7.640

View more
  10 in total

1.  Intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and regulated on activation normal T cell expressed and secreted are expressed by human breast carcinoma cells and support eosinophil adhesion and activation.

Authors:  S Ali; J Kaur; K D Patel
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

2.  Pivotal Advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response.

Authors:  Stephania A Cormier; Anna G Taranova; Carrie Bedient; Thanh Nguyen; Cheryl Protheroe; Ralph Pero; Dawn Dimina; Sergei I Ochkur; Katie O'Neill; Dana Colbert; Theresa R Lombari; Stephanie Constant; Michael P McGarry; James J Lee; Nancy A Lee
Journal:  J Leukoc Biol       Date:  2006-04-14       Impact factor: 4.962

3.  Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils.

Authors:  Anna-Lena Stenfeldt; Christine Wennerås
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

Review 4.  Eosinophils in glioblastoma biology.

Authors:  Colleen S Curran; Paul J Bertics
Journal:  J Neuroinflammation       Date:  2012-01-17       Impact factor: 8.322

5.  Influence of pathological tumour variables on long-term survival in resectable gastric cancer.

Authors:  A Cuschieri; I C Talbot; S Weeden
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

6.  Tumor-associated tissue eosinophilia predicts favorable clinical outcome in solid tumors: a meta-analysis.

Authors:  Guoming Hu; Shimin Wang; Kefang Zhong; Feng Xu; Liming Huang; Wei Chen; Pu Cheng
Journal:  BMC Cancer       Date:  2020-05-20       Impact factor: 4.430

7.  Quantitative Analysis of Tumor-associated Tissue Eosinophilia in Recurring Bladder Cancer.

Authors:  Hristo Popov; Ivan S Donev; Peter Ghenev
Journal:  Cureus       Date:  2018-09-10

Review 8.  Cervical Cancers: Varieties and the Lower Anogenital Squamous Terminology.

Authors:  Rasika Gadkari; R Ravi; Jasvinder Kaur Bhatia
Journal:  Cytojournal       Date:  2022-06-14       Impact factor: 2.345

Review 9.  Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development.

Authors:  Valérie Gouon-Evans; Elaine Y Lin; Jeffrey W Pollard
Journal:  Breast Cancer Res       Date:  2002-06-25       Impact factor: 6.466

10.  MethylResolver-a method for deconvoluting bulk DNA methylation profiles into known and unknown cell contents.

Authors:  Douglas Arneson; Xia Yang; Kai Wang
Journal:  Commun Biol       Date:  2020-08-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.